Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Lilium N.V. A | LILM | 5. nov 2024 | 0.08 | 0.00 |
Limbach | LMB | 5. nov 2024 | 77.79 | +5.72 |
Limoneira | LMNR | 5. nov 2024 | 27.20 | +5.63 |
Lincoln Educational Services | LINC | 5. nov 2024 | 13.83 | +3.36 |
Lincoln Electric | LECO | 5. nov 2024 | 203.79 | +2.51 |
Lincoln National | LNC | 5. nov 2024 | 32.78 | -0.40 |
Lincoln National Pref | LNC-D | 5. nov 2024 | 28.70 | +0.56 |
Lindblad Expeditions | LIND | 5. nov 2024 | 11.71 | +25.24 |
Linde | LIN | 5. nov 2024 | 454.89 | -0.75 |
Lindsay | LNN | 5. nov 2024 | 121.57 | +2.23 |
Lineage | LINE | 5. nov 2024 | 73.18 | +0.88 |
Lineage Cell Therapeutics | LCTX | 5. nov 2024 | 0.84 | +0.70 |
Linkage Global | LGCB | 5. nov 2024 | 0.24 | -7.13 |
Linkbancorp | LNKB | 5. nov 2024 | 7.04 | +3.38 |
Lion ADR | LGHL | 5. nov 2024 | 0.19 | +1.88 |
Lion Electric | LEV | 5. nov 2024 | 0.60 | +1.83 |
Lionheart Units | CUBWU | 5. nov 2024 | 10.04 | 0.00 |
Lions Gate Entertainment A | LGF-A | 5. nov 2024 | 8.01 | +1.39 |
Lions Gate Entertainment B | LGF-B | 5. nov 2024 | 7.12 | +1.42 |
Lipella Pharmaceuticals | LIPO | 5. nov 2024 | 0.32 | -5.95 |
Lipocine | LPCN | 5. nov 2024 | 5.83 | -4.27 |
LiqTech International | LIQT | 5. nov 2024 | 1.95 | +2.09 |
Liquidia | LQDA | 5. nov 2024 | 10.43 | -0.29 |
Liquidity Services | LQDT | 5. nov 2024 | 22.23 | +1.69 |
Lisata Therapeutics | LSTA | 5. nov 2024 | 2.88 | -1.03 |
Lithia Motors | LAD | 5. nov 2024 | 350.67 | +1.92 |
Lithium Americas | LAC | 5. nov 2024 | 4.17 | -0.71 |
Lithium Americas (Argentina) | LAAC | 5. nov 2024 | 3.52 | +0.57 |
Littelfuse | LFUS | 5. nov 2024 | 249.44 | +0.38 |
LivaNova | LIVN | 5. nov 2024 | 49.69 | +1.39 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.